Clear up the confusion in drug/biologicals audits
Health Care Auditing Strategies, March 1, 2009
This is an excerpt from a member only article. To read the article in its entirety, please login.
Accurate coding and billing of drug and biological commodities is a detailed process. Administration services for providing these drugs and biologicals are frequently the target of internal audit initiatives, but the actual substances are often overlooked. The performance of periodic internal audits will ensure sound charge capture, documentation, coding, and billing processes supporting the supply of drugs and biologicals.
This is an excerpt from a member only article. To read the article in its entirety, please login.
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- HealthDataInsights posts new issues for medical necessity claims
- Running an effective peer review committee meeting
- Q&A: Incidental disclosures and patient privacy
- New FAQ posted on storing laryngoscope blades
- Sneak Peek: Effort underway to establish caseload benchmarks
- Tip: Perform your own internal investigation prior to government audit
- What does case-mix index mean to you?
- HIPAA 5010 deadline extended, but threat remains, says AMA
- HHS task force: Consider privacy, security with text messages
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- What does case-mix index mean to you?
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- HHS task force: Consider privacy, security with text messages
- Tip: Correctly code bilateral pain management procedures
- Code changes should help ease the pain when coding for facet joint injections
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- COT basics to best
- Documentation and coding for toxic metabolic encephalopathy
- Searched
